Well im certainly no expert but the current GLOBAL market forcast for cell and gene therapy by 2032 is expected to be $44B.......ur talking msb alone to be a $50B company...so unless ur talking the next 10-15 (minimum)? Years then i personally think its unrealistic.....look,like i said iv got alot invested here and have been in and havent sold a share in 4+years and i hope im completely wrong on this but i just cant see $50aud per share at least in the next 10-15 years
Well im certainly no expert but the current GLOBAL market...
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.12 |
Change
0.015(1.36%) |
Mkt cap ! $1.278B | |||
| Open | High | Low | Value | Volume |
| $1.13 | $1.16 | $1.10 | $7.169M | 6.411M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 7296 | $1.12 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.12 | 43068 | 1 |
View Market Depth
| Last trade - 16.10pm 08/07/2024 (20 minute delay) ? |
| MSB (ASX) Chart |